1.Panchabhai TS, Mehta AC: Historical perspectives of bronchoscopy. Connecting the dots. Annals of the American Thoracic Society 2015, 12(5):631–641.
2.Poi PJ, Chuah SY, Srinivas P, Liam CK: Common fears of patients undergoing bronchoscopy. The European respiratory journal 1998, 11(5):1147–1149.
3.Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, Mandal S, Martin J, Mills J, Navani N et al: British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax 2013, 68(Suppl 1):i1.
4.José RJ, Shaefi S, Navani N: Sedation for flexible bronchoscopy: current and emerging evidence. European Respiratory Review 2013, 22(128):106.
5.Gaisl T, Bratton DJ, Heuss LT, Kohler M, Schlatzer C, Zalunardo MP, Frey M, Franzen D: Sedation during bronchoscopy: data from a nationwide sedation and monitoring survey. BMC Pulmonary Medicine 2016, 16(1):113.
6.Müller T, Thümmel K, Cornelissen CG, Krüger S, Dreher M: Analogosedation during flexible bronchoscopy using a combination of midazolam, propofol and fentanyl—A retrospective analysis. PLOS ONE 2017, 12(4):e0175394.
7.Ryu JH, Lee SW, Lee JH, Lee EH, Do SH, Kim CS: Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. British journal of anaesthesia 2012, 108(3):503–511.
8.Gao Y, Kang K, Liu H, Jia L, Tang R, Zhang X, Wang H, Yu K: Effect of dexmedetomidine and midazolam for flexible fiberoptic bronchoscopy in intensive care unit patients: A retrospective study. Medicine 2017, 96(25):e7090.
9.Chalumeau-Lemoine L, Stoclin A, Billard V, Laplanche A, Raynard B, Blot F: Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive care medicine 2013, 39(1):53–58.
10.Rezaiguia-Delclaux S, Laverdure F, Kortchinsky T, Lemasle L, Imbert A, Stephan F: Fiber optic bronchoscopy and remifentanil target-controlled infusion in critically ill patients with acute hypoxaemic respiratory failure: A descriptive study. Anaesthesia, critical care & pain medicine 2017, 36(5):273–277.
11.Oliveira R, Rosa R, Ascoli A, Rutzen W, Madeira L, Ghizzoni F, Khummer R, Vargas F, Lago L, Dietrich C et al: Factors influencing decline of physical functional status among icu survivors: a prospective cohort study. Intensive care medicine experimental 2015, 3(Suppl 1):A361.
12.Westmoreland CL, Hoke JF, Sebel PS, Hug CC, Jr., Muir KT: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993, 79(5):893–903.
13.Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Soukup J, Speelberg B, Kirkham AJT: Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004, 8(4):R268-R280.
14.Aldrete JA: The post-anesthesia recovery score revisited. Journal of clinical anesthesia 1995, 7(1):89–91.
15.Morris LG, Zeitler DM, Amin MR: Unsedated flexible fiberoptic bronchoscopy in the resident clinic: technique and patient satisfaction. The Laryngoscope 2007, 117(7):1159–1162.
16.Pickles J, Jeffrey M, Datta A, Jeffrey AA: Is preparation for bronchoscopy optimal? The European respiratory journal 2003, 22(2):203–206.
17.Gaisl T, Bratton DJ, Heuss LT, Kohler M, Schlatzer C, Zalunardo MP, Frey M, Franzen D: Sedation during bronchoscopy: data from a nationwide sedation and monitoring survey. BMC Pulm Med 2016, 16(1):113.
18.Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B et al: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. 2018, 46(9):e825-e873.
19.Burkle H, Dunbar S, Van Aken H: Remifentanil: a novel, short-acting, mu-opioid. Anesthesia and analgesia 1996, 83(3):646–651.
20.Breen D, Wilmer A, Bodenham A, Bach V, Bonde J, Kessler P, Albrecht S, Shaikh S: The offset of pharmacodynamic effects of remifentanil in ICU patients is not affected by renal impairment. In: Intensive care medicine: 2001: SPRINGER-VERLAG 175 FIFTH AVE, NEW YORK, NY 10010 USA; 2001: S207-S207.
21.Hoke JF, Shlugman D, Dershwitz M, Michałowski P, Malthouse-Dufore S, Connors PM, Martel D, Rosow CE, Muir KT, Rubin N: Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 1997, 87(3):533–541.
22.Dershwitz M, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, Dienstag JL: Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology: The Journal of the American Society of Anesthesiologists 1996, 84(4):812–820.
23.Gemma M, Tommasino C, Cozzi S, Narcisi S, Mortini P, Losa M, Soldarini A: Remifentanil Provides Hemodynamic Stability and Faster Awakening Time in Transsphenoidal Surgery. Anesthesia & Analgesia 2002, 94(1):163–168.
24.Lim JH, Ryu SJ, Lim YS: The incidence of cough induced by remifentanil during anesthetic induction was decreased by graded escalation of the remifentanil concentration. Korean J Anesthesiol 2010, 58(2):117–121.
25.Prakash N, McLeod T, Gao Smith F: The effects of remifentanil on haemodynamic stability during rigid bronchoscopy. Anaesthesia 2001, 56(6):576–580.
26.Reyle-Hahn M, Niggemann B, Max M, Streich R, Rossaint R: Remifentanil and propofol for sedation in children and young adolescents undergoing diagnostic flexible bronchoscopy. Paediatric anaesthesia 2000, 10(1):59–63.
27.Berkenbosch JW, Graff GR, Stark JM, Ner Z, Tobias JD: Use of a remifentanil-propofol mixture for pediatric flexible fiberoptic bronchoscopy sedation. Paediatric anaesthesia 2004, 14(11):941–946.